Literature DB >> 23768969

Trends in incidence of breast cancer among women under 40 in seven European countries: a GRELL cooperative study.

Brice Leclère1, Florence Molinié, Brigitte Trétarre, Fabrizio Stracci, Laetitia Daubisse-Marliac, Marc Colonna.   

Abstract

Young women are not usually screened for breast cancer (BC). The trends in incidence in this population may better reflect changes in risk factors. However, studies on this subject are scarce and heterogeneous. The aim of this study was to describe the trends in incidence of BC in women under 40 from 1990 to 2008, using pooled European data. Thirty-seven European population-based cancer registries from Belgium, Bulgaria, France, Italy, Portugal, Spain and Switzerland participated in this study. World age-standardized incidence rates were first analyzed graphically and then using a Poisson regression model, in order to estimate average annual percent changes (AAPCs). The overall incidence rate of BC in the area covered increased linearly during the study period by 1.19% (0.93; 1.46) on average per year. This increase varied between countries from 0.20% (-0.53; 0.64) in Bulgaria to 2.68% (1.97; 3.40) in Portugal. In Italy, after a significant rise of 2.33% (1.14; 3.54) per year, BC incidence began decreasing in 2002 by -2.30% (-4.07; -0.50) yearly. The rise in incidence was greater for women under 35 and for ductal carcinomas. This increase can be due to a rise in risk factors and/or changes in diagnosis and surveillance practices, but we could not clearly distinguish between these two non-exclusive explanations.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast carcinoma; Epidemiology; Incidence; Registries; Young adult

Mesh:

Year:  2013        PMID: 23768969     DOI: 10.1016/j.canep.2013.05.001

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  22 in total

1.  Age-standardized cancer-incidence trends in Canada, 1971-2015.

Authors:  Darren R Brenner; Yibing Ruan; Eileen Shaw; Dylan O'Sullivan; Abbey E Poirier; Emily Heer; Paul J Villeneuve; Stephen D Walter; Christine M Friedenreich; Leah Smith; Prithwish De
Journal:  CMAJ       Date:  2019-11-18       Impact factor: 8.262

2.  Presentation and characteristics of breast cancer in young women under age 40.

Authors:  Xueying Hu; Kelly S Myers; Eniola T Oluyemi; Mary Philip; Armina Azizi; Emily B Ambinder
Journal:  Breast Cancer Res Treat       Date:  2020-11-02       Impact factor: 4.872

Review 3.  Breast cancer in adolescents and young adults.

Authors:  Rebecca H Johnson; Carey K Anders; Jennifer K Litton; Kathryn J Ruddy; Archie Bleyer
Journal:  Pediatr Blood Cancer       Date:  2018-08-28       Impact factor: 3.167

4.  Comparison of the seleno-transcriptome expression between human non-cancerous mammary epithelial cells and two human breast cancer cell lines.

Authors:  Fabiola Rusolo; Francesca Capone; Raffaella Pasquale; Antonella Angiolillo; Giovanni Colonna; Giuseppe Castello; Maria Costantini; Susan Costantini
Journal:  Oncol Lett       Date:  2017-02-13       Impact factor: 2.967

5.  Clinical features and prognostic factors of breast cancer in young women: a retrospective single-center study.

Authors:  Weigang Wang; Baoguo Tian; Xiaoqin Xu; Xiaofang Zhang; Yan Wang; Lili Du; Jiexian Jing
Journal:  Arch Gynecol Obstet       Date:  2022-07-15       Impact factor: 2.493

6.  Evaluation of Reproductive Concerns and Biographical Impact of Breast Cancer in Young Patients.

Authors:  Maximiliane Burgmann; Kerstin Hermelink; Alex Farr; Friederike van Meegen; Annika Heiduschk; Jutta Engel; Thomas Kolben; Tom Degenhardt; Nina Ditsch; Sven Mahner; Nadia Harbeck; Rachel Würstlein
Journal:  Breast Care (Basel)       Date:  2018-02-01       Impact factor: 2.860

7.  Comparative hematological profiles for dose-dense vs. regular anthracycline-based neoadjuvant chemotherapy in non-metastatic breast cancer.

Authors:  Dorel Popovici; Cristina Oprean; Sorin Săftescu; Alina Negru; Mihnea Munteanu; Horia T Stanca; Adrian Teodoru; Simona Stanca; Șerban Negru
Journal:  Exp Ther Med       Date:  2021-05-11       Impact factor: 2.447

8.  Effects of combination therapy of docetaxel with selenium on the human breast cancer cell lines MDA-MB-231 and MCF-7.

Authors:  Sang O Park; Young Bum Yoo; Yong Hun Kim; Kwang Je Baek; Jung-Hyun Yang; Pil Cho Choi; Jeong Hun Lee; Kyeong Ryong Lee; Kyoung Sik Park
Journal:  Ann Surg Treat Res       Date:  2015-01-27       Impact factor: 1.859

9.  Premenopausal breast cancer: potential clinical utility of a multi-omics based machine learning approach for patient stratification.

Authors:  Holger Fröhlich; Sabyasachi Patjoshi; Kristina Yeghiazaryan; Christina Kehrer; Walther Kuhn; Olga Golubnitschaja
Journal:  EPMA J       Date:  2018-04-11       Impact factor: 6.543

Review 10.  Triple negative breast cancer: looking for the missing link between biology and treatments.

Authors:  Giuseppe Palma; Giuseppe Frasci; Andrea Chirico; Emanuela Esposito; Claudio Siani; Carmela Saturnino; Claudio Arra; Gennaro Ciliberto; Antonio Giordano; Massimiliano D'Aiuto
Journal:  Oncotarget       Date:  2015-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.